Fuller & Thaler Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-985,660
| Closed | -$1.81M | – | 547 |
|
|
2023
Q2 | $1.81M | Buy |
985,660
+3,125
| +0.3% | +$5.75K | 0.01% | 366 |
|
|
2023
Q1 | $2.39M | Sell |
982,535
-750
| -0.1% | -$1.82K | 0.01% | 332 |
|
|
2022
Q4 | $1.41M | Buy |
983,285
+12,275
| +1% | +$17.6K | 0.01% | 363 |
|
|
2022
Q3 | $2.17M | Buy |
971,010
+13,525
| +1% | +$30.2K | 0.02% | 326 |
|
|
2022
Q2 | $1.98M | Buy |
957,485
+6,250
| +0.7% | +$12.9K | 0.01% | 351 |
|
|
2022
Q1 | $2.76M | Buy |
951,235
+4,950
| +0.5% | +$14.4K | 0.02% | 337 |
|
|
2021
Q4 | $3.04M | Buy |
946,285
+4,525
| +0.5% | +$14.5K | 0.02% | 319 |
|
|
2021
Q3 | $3.33M | Sell |
941,760
-4,425
| -0.5% | -$15.7K | 0.02% | 288 |
|
|
2021
Q2 | $3M | Buy |
+946,185
| New | +$3M | 0.02% | 305 |
|
|
2017
Q1 | – | Sell |
-9,300
| Closed | -$65K | – | 761 |
|
|
2016
Q4 | $65K | Hold |
9,300
| – | – | ﹤0.01% | 573 |
|
|
2016
Q3 | $47K | Hold |
9,300
| – | – | ﹤0.01% | 608 |
|
|
2016
Q2 | $56K | Hold |
9,300
| – | – | ﹤0.01% | 559 |
|
|
2016
Q1 | $42K | Buy |
+9,300
| New | +$42K | ﹤0.01% | 578 |
|